FCMI
BITI

Foresite Capital Management II’s BIOTIE THERAPIES CORP SPONSORED ADR BITI Stock Holding History

Foresite Capital Management II’s Portfolio BITI Stock Details BITI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-80,883
Closed -$1.06M – 28
2015
Q3 		$1.06M Sell
80,883
-108,017
-57% -$1.9M 0.32% 27
2015
Q2 		$3.77M Buy
+188,900
New +$3.94M 1.32% 16

Other funds holding BITI

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Foresite Capital Management II's BITI Position: Q4 2015 in Review

Foresite Capital Management II sold out of BIOTIE THERAPIES CORP SPONSORED ADR (BITI) in Q4 2015, closing a stake of 80,883 shares — an estimated $1.06M sold.

Foresite Capital Management II first reported a position in BITI in Q2 2015 and held it in 2 quarters. The position peaked at $3.77M in Q2 2015. 15 funds tracked by Wall St. Rank hold BITI as of Q4 2015.

  • Foresite Capital Management II reported no remaining BIOTIE THERAPIES CORP SPONSORED ADR position as of Q4 2015 after selling out during the quarter.
  • Foresite Capital Management II sold 80,883 BIOTIE THERAPIES CORP SPONSORED ADR shares in Q4 2015, an estimated $1.06M.
  • Foresite Capital Management II first reported a position in BIOTIE THERAPIES CORP SPONSORED ADR in Q2 2015 and held it in 2 quarters.
  • Foresite Capital Management II's BIOTIE THERAPIES CORP SPONSORED ADR position peaked at $3.77M in Q2 2015.
  • 15 funds tracked by Wall St. Rank held BIOTIE THERAPIES CORP SPONSORED ADR as of Q4 2015.

Based on Foresite Capital Management II's 13F filing for Q4 2015, filed 12 Feb 2016.